Pasithea Therapeutics Corp (KTTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 3,213 | 4,043 | 3,856 | 2,612 | 2,079 |
| Operating Income | -3,213 | -4,043 | -3,856 | -2,612 | -2,079 |
| Other Income | -53 | -11 | -335 | 422 | 785 |
| Pre-tax Income | -3,266 | -4,053 | -4,191 | -2,190 | -1,294 |
| Net Income Continuous | -3,266 | -4,053 | -4,191 | -2,190 | -1,294 |
| Net Income Discontinuous | -272 | -1,064 | -395 | -469 | -281 |
| Net Income | $-3,538 | $-5,118 | $-4,586 | $-2,658 | $-1,574 |
| EPS Basic Total Ops | -2.71 | -4.23 | -3.40 | -2.20 | -1.20 |
| EPS Basic Continuous Ops | -2.60 | -3.17 | -3.20 | -1.80 | -1.12 |
| EPS Basic Discontinuous Ops | -0.20 | -0.90 | -0.20 | -0.40 | -0.24 |
| EPS Diluted Total Ops | -2.71 | -4.23 | -3.40 | -2.20 | -1.20 |
| EPS Diluted Continuous Ops | -2.60 | -3.17 | -3.20 | -1.80 | -1.12 |
| EPS Diluted Discontinuous Ops | -0.20 | -0.90 | -0.20 | -0.40 | -0.24 |
| EBITDA(a) | $-3,051 | $-4,039 | $-3,856 | $-2,612 | $-2,079 |